MedTrace Logo

Hypertonic Saline Nasal Irrigation and Gargling (HSNIG) for Suspected COVID-19 in Pakistan

NCT05104372 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 405

Last updated 2021-11-03

No results posted yet for this study

Summary

Nasal washing (washout) followed by gargles with hypertonic saline (HSNIG) is believed to be effective in reducing the duration of illness in those with clinically suspected or confirmed COVID-19 being managed at home, and also is effective in reducing complications of COVID-19 and onward household transmission.

This study plans to investigate whether the use of HSNIG performed by adults with symptoms consistent with COVID-19 reduces the duration of symptoms when compared to participants managed using standard care.

Conditions

Interventions

OTHER

Hypertonic Saline Nasal Irrigation and Gargles (HSNIG)

Nasal washout and gargles

Sponsors & Collaborators

  • University of Edinburgh

    collaborator OTHER

  • The Allergy and Asthma Institute, Pakistan

    lead OTHER

Principal Investigators

  • Aziz Sheikh, MD, PhD · University of Edinburgh

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-01
Primary Completion
2021-11-15
Completion
2021-11-30

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05104372 on ClinicalTrials.gov